Valo Early Discovery, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Valo Early Discovery, Inc..The latest application filed is for "alpha-cinnamide compounds and compositions as hdac8 inhibitors".

Company Profile

29.29.18

Valo Early Discovery, Inc. - Boston MA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Alpha-cinnamide Compounds And Compositions As Hdac8 Inhibitors App 20220073452 - Bair; Kenneth W. ; et al.	2022-03-10
Pyrrolo And Pyrazolopyrimidines As Ubiquitin-specific Protease 7 Inhibitors App 20210332052 - Ioannidis; Stephanos ; et al.	2021-10-28
Carboxamides As Ubiquitin-specific Protease Inhibitors App 20210323975 - GUERIN; David J. ; et al.	2021-10-21
Isothiazolopyrimidinones, Pyrazolopyrimidinones, And Pyrrolopyrimidinones As Ubiquitin-specific Protease 7 Inhibitors App 20210323978 - Ioannidis; Stephanos ; et al.	2021-10-21
Thienopyrimidinones As Ubiquitin-specific Protease 7 Inhibitors App 20210292337 - Ioannidis; Stephanos ; et al.	2021-09-23
Isoindolines As Hdac Inhibitors App 20210253555 - ZHENG; Xiaozhang ; et al.	2021-08-19
Piperidine Derivatives And Compositions For The Inhibition Of Nicotinamide Phosphoribosyltransferase (nampt) App 20210246147 - Bair; Kenneth W. ; et al.	2021-08-12
Novel Compounds And Compositions For The Inhibition Of Nampt App 20210244717 - Bair; Kenneth W. ; et al.	2021-08-12
Bicyclic [4,6,0] Hydroxamic Acids As Hdac Inhibitors App 20210206755 - Zheng; Xiaozhang ; et al.	2021-07-08
2-spiro-5- And 6-hydroxamic Acid Indanes As Hdac Inhibitors App 20210186940 - Zheng; Xiaozhang ; et al.	2021-06-24
Inhibiting Deubiquitinase Usp25 And Usp28 App 20210179628 - GUERIN; David J. ; et al.	2021-06-17
[6,6] Fused Bicyclic Hdac8 Inhibitors App 20210139439 - Zheng; Xiaozhang ; et al.	2021-05-13
Quinazolinones And Azaquinazolinones As Ubiquitin-specific Protease 7 Inhibitors App 20210130321 - Ioannidis; Stephanos ; et al.	2021-05-06
Alpha-cinnamide compounds and compositions as HDAC8 inhibitors Grant 10,988,441 - Bair , et al. April 27, 2	2021-04-27
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Grant 10,988,450 - Zheng , et al. April 27, 2	2021-04-27
Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors Grant 10,981,915 - Ioannidis , et al. April 20, 2	2021-04-20
Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors Grant 10,934,299 - Ioannidis , et al. March 2, 2	2021-03-02
Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors Grant 10,927,130 - Ioannidis , et al. February 23, 2	2021-02-23
Thienopyrazine Carboxamides As Ubiquitin-specific Protease Inhibitors App 20210047343 - Guerin; David Joseph ; et al.	2021-02-18
Thienopyridine carboxamides as ubiquitin-specific protease inhibitors Grant 10,913,753 - Guerin , et al. February 9, 2	2021-02-09
Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors Grant 10,906,916 - Ioannidis , et al. February 2, 2	2021-02-02
3-alkyl Bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors App 20210009539 - Zheng; Xiaozhang ; et al.	2021-01-14
3-aryl-4-amido-bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors App 20210009538 - Zheng; Xiaozhang ; et al.	2021-01-14
3-aryl-bicyclic [4,5,0] Hydroxamic Acids As Hdac Inhibitors App 20210009540 - Zheng; Xiaozhang ; et al.	2021-01-14
Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors Grant 10,889,592 - Guerin , et al. January 12, 2	2021-01-12
2-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitors Grant 10,874,649 - Zheng , et al. December 29, 2	2020-12-29
Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors Grant 10,870,645 - Zheng , et al. December 22, 2	2020-12-22
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors Grant 10,836,741 - Ioannidis , et al. November 17, 2	2020-11-17
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Grant 10,829,462 - Zheng , et al. November 10, 2	2020-11-10
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Grant 10,829,461 - Zheng , et al. November 10, 2	2020-11-10
[6,6] fused bicyclic HDAC8 inhibitors Grant 10,829,460 - Zheng , et al. November 10, 2	2020-11-10
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors Grant 10,822,316 - Zheng , et al. November 3, 2	2020-11-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.